A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia

Published:2011-09-24 Issue:3 Volume:220 Page:591-598
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Arbabi Mohammad,Bagheri Mohaddeseh,Rezaei Farzin,Ahmadi-Abhari Seyyed-Ali,Tabrizi Mina,Khalighi-Sigaroudi Farahnaz,Akhondzadeh Shahin

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-011-2513-z.pdf

Reference27 articles.

1. Abolfazli R, Hosseini M, Ghanizadeh A, Ghaleiha A, Tabrizi M, Raznahan M, Golalizadeh M, Akhondzadeh S (2011) Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression. Depress Anxiety 28:297–302

2. Akhondzadeh S (2006) Pharmacotherapy of schizophrenia: the past, present and future. Curr Drug Therapy 1:1–7

3. Akhondzadeh S, Rezaei F, Larijani B, Nejatisafa AA, Kashani L, Abbasi SH (2006) Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophr Res 84:405–410

4. Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi-Abhari SA, Abbasi SH, Behnam B (2007) Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr Res 90:179–185

5. Akhondzadeh S, Ghayyoumi R, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, Naderi M, Ghebleh F, Tabrizi M, Rezazadeh SA (2011) Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial. Psychopharmacology 213:809–815

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effectiveness of Augmenting Modafinil to Risperidone or Olanzapine for Treating Negative Symptoms in Schizophrenic Patients: A Randomized Controlled Trail;Jundishapur Journal of Chronic Disease Care;2024-03-13

2. Uso de sustancias psicoactivas como tratamiento de la psicosis;Revista de Neurología;2023

3. Dopamine partial agonists and prodopaminergic drugs for schizophrenia: Systematic review and meta-analysis of randomized controlled trials;Neuroscience & Biobehavioral Reviews;2022-04

4. Modafinil in the treatment of selected mental disorders;Psychiatria i Psychologia Kliniczna;2021-11-10

5. Modafinil for people with schizophrenia or related disorders;Cochrane Database of Systematic Reviews;2019-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3